Aurobac Therapeutics SAS
1 clinical trials · Sponsor
◉ Watch Aurobac Therapeutics SAS
| Record | Firm | Date |
|---|---|---|
| Phase 1 Single Ascending Dose Study With ATX101 (NCT07107802) | Aurobac Therapeutics SAS | 2025-07-19 |
Track Aurobac Therapeutics SAS automatically
Every clearance here is in the API, with alerts when new ones post.